Article

Π-Π Interactions Stabilize PeptoMicelle-Based Formulations of Pretomanid Derivatives…

medRxiv · 2022 · Dal, N.-J. K.; Schafer, G.; Thompson, A. M.; Schmitt, S.; Redinger, N.; Alonso-Rodriguez, N.; Johann, K.; Ojong, J.; Wohlmann, J.; Best, A.; Koynov, K.; Zentel, R.; Shaible, U. E.; Griffiths, G.; Barz, M.; Fenaroli, F.

Key facts

Title Π-Π Interactions Stabilize PeptoMicelle-Based Formulations of Pretomanid Derivatives Leading to Promising Therapy Against Tuberculosis in Zebrafish and Mouse Models
First author Dal, N.-J. K.; Schafer, G.; Thompson, A. M.; Schmitt, S.; Redinger, N.; Alonso-Rodriguez, N.; Johann, K.; Ojong, J.; Wohlmann, J.; Best, A.; Koynov, K.; Zentel, R.; Shaible, U. E.; Griffiths, G.; Barz, M.; Fenaroli, F.
Journal medRxiv
Published Mar 11, 2022
DOI 10.1101/2022.03.10.483770
Devices mentioned K120877
Product codes mentioned IDO, IDW, IDZ, IEO, KDT, KEQ, KER, KES, KIM, KIO, NNK, PPM and 1 more

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature